74 related articles for article (PubMed ID: 9095654)
1. [The signal transduction mechanism of IL-4 in X-linked severe combined immunodeficiency patients].
Izuhara K
Rinsho Ketsueki; 1997 Mar; 38(3):186-8. PubMed ID: 9095654
[No Abstract] [Full Text] [Related]
2. Interleukin 4 and interleukin 13: same response, different receptors.
Callard RE; Matthews DJ; Hibbert LM
Biochem Soc Trans; 1997 May; 25(2):451-5. PubMed ID: 9191134
[No Abstract] [Full Text] [Related]
3. Sharing of receptor subunits and signal transduction pathway between the IL-4 and IL-13 receptor system.
Murata T; Taguchi J; Puri RK; Mohri H
Int J Hematol; 1999 Jan; 69(1):13-20. PubMed ID: 10641437
[TBL] [Abstract][Full Text] [Related]
4. Signaling via the IL-2 and IL-7 receptors from the membrane to the nucleus.
Leonard WJ; Imada K; Nakajima H; Puel A; Soldaini E; John S
Cold Spring Harb Symp Quant Biol; 1999; 64():417-24. PubMed ID: 11232316
[No Abstract] [Full Text] [Related]
5. A critical role for IL-21 in regulating immunoglobulin production.
Ozaki K; Spolski R; Feng CG; Qi CF; Cheng J; Sher A; Morse HC; Liu C; Schwartzberg PL; Leonard WJ
Science; 2002 Nov; 298(5598):1630-4. PubMed ID: 12446913
[TBL] [Abstract][Full Text] [Related]
6. Atypical X-linked severe combined immunodeficiency due to possible spontaneous reversion of the genetic defect in T cells.
Stephan V; Wahn V; Le Deist F; Dirksen U; Broker B; Müller-Fleckenstein I; Horneff G; Schroten H; Fischer A; de Saint Basile G
N Engl J Med; 1996 Nov; 335(21):1563-7. PubMed ID: 8900089
[No Abstract] [Full Text] [Related]
7. X-linked SCID and other defects of cytokine pathways.
Uribe L; Weinberg KI
Semin Hematol; 1998 Oct; 35(4):299-309. PubMed ID: 9801259
[TBL] [Abstract][Full Text] [Related]
8. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency.
Puel A; Ziegler SF; Buckley RH; Leonard WJ
Nat Genet; 1998 Dec; 20(4):394-7. PubMed ID: 9843216
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-4 signaling in B lymphocytes from patients with X-linked severe combined immunodeficiency.
Taylor N; Candotti F; Smith S; Oakes SA; Jahn T; Isakov J; Puck JM; O'Shea JJ; Weinberg K; Johnston JA
J Biol Chem; 1997 Mar; 272(11):7314-9. PubMed ID: 9054429
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4.
Yu CR; Kirken RA; Malabarba MG; Young HA; Ortaldo JR
J Immunol; 1998 Jul; 161(1):218-27. PubMed ID: 9647227
[TBL] [Abstract][Full Text] [Related]
11. Signal transducer and activator of transcription 5 tyrosine phosphorylation for the diagnosis and monitoring of patients with severe combined immunodeficiency.
Walshe D; Gaspar HB; Thrasher AJ; Cale CM; Gilmour KC
J Allergy Clin Immunol; 2009 Feb; 123(2):505-8. PubMed ID: 19203666
[No Abstract] [Full Text] [Related]
12. IL-13R(alpha)2, a decoy receptor for IL-13 acts as an inhibitor of IL-4-dependent signal transduction in glioblastoma cells.
Rahaman SO; Sharma P; Harbor PC; Aman MJ; Vogelbaum MA; Haque SJ
Cancer Res; 2002 Feb; 62(4):1103-9. PubMed ID: 11861389
[TBL] [Abstract][Full Text] [Related]
13. Mutations in the gene for the IL-7 receptor result in T(-)B(+)NK(+) severe combined immunodeficiency disease.
Puel A; Leonard WJ
Curr Opin Immunol; 2000 Aug; 12(4):468-73. PubMed ID: 10899029
[TBL] [Abstract][Full Text] [Related]
14. [Involvement of IL-4 and IL-13 signals in the pathogenesis of bronchial asthma].
Izuhara K
Arerugi; 2005 Jan; 54(1):7-11. PubMed ID: 15841670
[No Abstract] [Full Text] [Related]
15. Severe combined immunodeficiency due to a defect in the tyrosine kinase ZAP-70.
Elder ME
Pediatr Res; 1996 May; 39(5):743-8. PubMed ID: 8726223
[No Abstract] [Full Text] [Related]
16. Signal transduction pathway of interleukin-4 and interleukin-13 in human B cells derived from X-linked severe combined immunodeficiency patients.
Izuhara K; Heike T; Otsuka T; Yamaoka K; Mayumi M; Imamura T; Niho Y; Harada N
J Biol Chem; 1996 Jan; 271(2):619-22. PubMed ID: 8557662
[TBL] [Abstract][Full Text] [Related]
17. Mutations in the tyrosine phosphatase CD45 gene in a child with severe combined immunodeficiency disease.
Kung C; Pingel JT; Heikinheimo M; Klemola T; Varkila K; Yoo LI; Vuopala K; Poyhonen M; Uhari M; Rogers M; Speck SH; Chatila T; Thomas ML
Nat Med; 2000 Mar; 6(3):343-5. PubMed ID: 10700239
[TBL] [Abstract][Full Text] [Related]
18. Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15.
Matthews DJ; Clark PA; Herbert J; Morgan G; Armitage RJ; Kinnon C; Minty A; Grabstein KH; Caput D; Ferrara P
Blood; 1995 Jan; 85(1):38-42. PubMed ID: 7803808
[TBL] [Abstract][Full Text] [Related]
19. The molecular basis of X-linked agammaglobulinemia, hyper-IgM syndrome, and severe combined immunodeficiency in humans.
Aruffo A; Hollenbaugh D; Wu LH; Ochs HD
Curr Opin Hematol; 1994 Jan; 1(1):12-8. PubMed ID: 9371254
[TBL] [Abstract][Full Text] [Related]
20. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
